# A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

> **NCT05960006** · — · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 20 (actual)

## Conditions studied

- Antibiotic Toxicity
- Liver Cirrhosis
- Renal Insufficiency
- Ceftriaxone Overdose
- Ascites Hepatic
- Infection, Bacterial

## Interventions

- **OTHER:** No intervention (observational study)

## Key facts

- **NCT ID:** NCT05960006
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-10
- **Primary completion:** 2025-04-10
- **Final completion:** 2026-01-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05960006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05960006, "A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05960006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*